General Information of DTT (ID: TTIL516)

DTT Name CCN2 messenger RNA (CCN2 mRNA) DTT Info
Gene Name CCN2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
OLX10010 DMXL7HO Hypertrophic scars EE60 Phase 2 [1]
PF-06473871 DM9S3P7 Hypertrophic scars EE60 Phase 2 [2]
RXI-109 DMXG9ES Fibrosis GA14-GC01 Phase 2 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Olix Pharmaceuticals.
2 A Placebo-controlled Study of PF-06473871 (Anti-Connective Tissue Growth Factor Antisense Oligonucleotide) in Reducing Hypertrophic Skin Scarring. Plast Reconstr Surg Glob Open. 2018 Sep 6;6(9):e1861.
3 The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2019 Jun;18(6):421-446.